Recordati (OTC:RCDTF) Stock, Quote.Headers.trade-ideas

Recordati SpA is a drug manufacturing company that focuses on specialty pharmaceuticals. The company produces and promotes medicines globally that focus on primary-care therapies and rare diseases. Recordati uses strategic partnerships as part of its long-term growth. The vast majority of the company's revenue is generated in Italy, followed by the United States, France, and Germany. Recordati reports two operating segments: Specialty and Primary care and Rare diseases. The bulk of the company's profit is derived from its specialty and primary care segment which includes the production of active ingredients.

RECORDATI INDUSTRIA CHIM by Recordati Industria Chimica e Farmaceutica S.p.A.

Recordati SpA

Recordati Industria Chimica e Farmaceutica SPA (IT:REC) has released an update. Recordati S.p.A. has successfully concluded its share buyback progr...

Recordati Completes Share Buyback Program

Recordati Industria Chimica e Farmaceutica SPA (IT:REC) has released an update. Recordati S.p.A. has successfully completed its share buy-back prog...

Recordati Completes Share Buy-Back Program

Recordati Industria Chimica e Farmaceutica SPA (IT:REC) has released an update. Recordati S.p.A. has announced a share buy-back program aimed at su...

Recordati Launches Share Buy-Back Program to Boost Incentives

In a report released on November 11, Niccolo Guido Storer from Kepler Capital maintained a Hold rating on Recordati Industria Chimica e Farmaceutic...

Kepler Capital  Reaffirms Their Hold Rating on Recordati Industria Chimica e Farmaceutica SPA (0KBS)

Recordati Industria Chimica e Farmaceutica SPA (IT:REC) has released an update. Recordati S.p.A. has actively engaged in its share buyback program,...

Recordati's Strategic Share Buyback Initiative

RBC Capital analyst Alistair Campbell maintained a Hold rating on Recordati Industria Chimica e Farmaceutica SPA (0KBS – Research Report) on Novemb...

RBC Capital Reaffirms Their Hold Rating on Recordati Industria Chimica e Farmaceutica SPA (0KBS)

Recordati Industria Chimica e Farmaceutica SPA (IT:REC) has released an update. Recordati S.p.A. has executed a series of share buyback transaction...

Recordati Executes Share Buyback Program

Recordati Industria Chimica e Farmaceutica SPA (IT:REC) has released an update. Recordati has successfully acquired global rights to Enjaymo&#xAE;, a gr...

Recordati Bolsters Portfolio with Enjaymo® Acquisition

RBC Capital analyst Alistair Campbell maintained a Hold rating on Recordati Industria Chimica e Farmaceutica SPA (0KBS – Research Report) on Decemb...

RBC Capital Keeps Their Hold Rating on Recordati Industria Chimica e Farmaceutica SPA (0KBS)

The latest announcement is out from Recordati Industria Chimica e Farmaceutica SPA ( ($IT:REC) ). Recordati S.p.A. has announced updates on its sha...

Comments

Recordati

Recordati (RCDTF) Forecast

Recordati (OTC:RCDTF) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga